07,00-07,30 General matters SM CIBMTR cooperation (10’ + 5’ discussion)- AS/PD Haplo position paper (10’ + 5’ discussion)-AT/HS/SD 07,30-07,40 Educational issues AS Update on Palma 2018 ?Bids for 2019 (Bristol) Proposals for upcoming venues 07,40-07,50 Manuscript status SM 2007-R-01 HL auto late effects update (AS/PD), paper to be circulated to WC/authors 2006-R-02 RIC in MCL (SR), accepted BMT 2018 2009-R-06 FL unrelated; (AS, with CIBMTR) accepted Cancer 2018 2010-N-02 WM auto; (CK), 1st draft written 2011-R-01 PMBCL auto; IA accepted BMT 2018 2012-R-04 MALT; AC/SM, rejected AO, submitted to BJH (12/1/18) 2012-R02E CTCL recent era; RD/ED, with PD 2013-N-02i Pwi prior to SCT; PD, rejected by Blood/JCO/ Lancet Hematology/ Haematologica; submitted to BMT (27/02/18) 2013-N-02, 2016-R-01 PWI pre and post allo studies (PD, with CMWP) 202014-R-01 alloWM (CK); for JCO? 2015-R-05 Allo in NHL according to age; CK/PD, submitted to BBMT (04/03/18) 2015-R-04 HIV new era (KH); draft with WC, for JCO 2015-R-03 Rel after auto DLBCL (EG/AS)-paper 2018 2015-R-09 FL Rel post auto in FL (SR)- paper 2018 2015-R-06 SCT in NLP-HL (SA/AS), accepted AJH 2017 2015-R-01A BV as bridge to SCT in ALCL (AS/ED)-papers 2018 2015-R-01H BV as bridge to SCT in HL (AB/AS), accepted BJH 2018 2015-R-01H BV post allo in HL (AB/AS)- 1st draft 2015-R-08 Haplo in DLBCL (PD/AS with CIBMTR) 2015-R-09 FL Rel post auto in FL (SR)- paper 2018 2016-R-05 BEAC toxicity (SR); BMT 4 minor review-deadline 4 resubmission 21/3/18 2017-R-01 trends in SCT in FL; (SR) 07,50-08,10 Ongoing LWP studies All 2009-N-02 SCT in blastic plasmocytoid dendritic cell neoplasia (SD with ALWP) -SD 2016-S-01 Checkpoint inhibitors pre/post alloHCT (SD/PD/AS) 2016-R-02 DLI in lymphoma- 692 patients- for analysis 2016-R-04 2nd auto in HL-67 patients- data cleaning 2017-R-02 Haplo- 495 patients- data entry 2017-R-05 Ibru post ASCT MCL- data collection 08,10-08,15 Abstracts for 2018 SM EBMT (2 orals + 3 posters) EHA (3 submitted) ASCO (1 submitted) ISHL IWWM ASH 08,15-08,20 Next studies to be launched SM 2017-R-04 PT-Cy-LC/SB-pt final protocol 2017-NIS-01 haplo vs other- LC 08,20-08,50 New proposals All Haplo vs cord- V Rocha (10’ + 5’ discussion) Tandem auto-RIC in HL- L Bento (10’ + 5’ discussion) 08,50-09,00 Any other business All 09,00 Adjourn